View of Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: 32-Week Data From a Randomized, Phase 2 Study

Return to Article Details Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: 32-Week Data From a Randomized, Phase 2 Study Download Download PDF